Who is sponsoring NCT03170934?

NCT03170934 is sponsored by University of Manitoba.

What drugs are being tested in NCT03170934?

Interventions in NCT03170934: Psychotherapy skills class.

What condition does NCT03170934 study?

NCT03170934 studies Suicidal Ideation.

Is NCT03170934 still recruiting?

NCT03170934 is currently completed. Last updated 23 April 2019.

Last reviewed 2019-04-23 · How we verify

NCT03170934

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effectiveness of Psychotherapy Classes in Reducing Suicidal Ideation

Completed Last updated 23 April 2019

What this trial tests

trial testing Psychotherapy skills class in Suicidal Ideation in 63 participants. Completed in 30 October 2018.

Timeline

31 May 2017

Primary endpoint
30 October 2018

30 October 2018

Quick facts

Lead sponsor	University of Manitoba
Status	Completed
Study type	OBSERVATIONAL
Enrollment	63
Start date	31 May 2017
Primary completion	30 October 2018
Estimated completion	30 October 2018
Sites	1 location across Canada

Drugs / interventions tested

Psychotherapy skills class

Conditions studied

Suicidal Ideation — all drugs for Suicidal Ideation →

Sponsor

University of Manitoba

Who can join

18 and older, any sex, with Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study will conduct a preliminary investigation of the effectiveness of two different psychotherapy classes at the Mental Health Crisis Response Centre (CRC) in reducing suicidal ideation. One class - Managing Difficult Emotions (MDE) - is an 8-session, Dialectical Behavioral Therapy-informed program that focuses on skills related to increasing tolerance for distress and emotion regulation such that harmful behaviors are reduced. The other class - Mindfulness-Based Cognitive Behavioral Therapy (CBTm) - is a 4-session program that focuses on challenging and changing maladaptive beliefs and behaviors in order to reduce distress. Both classes are delivered in lecture style, PowerPoint format. The investigators will also examine the effectiveness of participation in psychotherapy classes in reducing symptoms of general psychological distress, depression, anxiety, and emotion dysregulation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Suicidal Ideation

Currently open trials in the same condition.

NCT07438912 — Mind After Midnight · NA · recruiting
NCT07238192 — Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD · NA · recruiting
NCT07217444 — Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation · NA · recruiting
NCT07259408 — Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior · recruiting
NCT07305701 — Cohort Study on Medical Students' Mental Health · recruiting

Other University of Manitoba trials

Trials by the same sponsor.

NCT07528417 — Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · Phase 2 · not yet recruiting
NCT07366515 — Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients · NA · not yet recruiting
NCT07354386 — Effects of Dried Whole Fruits on Metabolism in Diabetes · NA · enrolling by invitation
NCT07361315 — Development and Online Evaluation of an Online Course for Parasomnias · NA · recruiting
NCT07023744 — CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03170934 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Manitoba
Last refreshed: 23 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03170934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing